The relationship between serum tumor-associated trypsin inhibitor levels and clinicopathological parameters in patients with gastric cancer

Sadeleştirilmiş öğe sayfası
dc.contributor.authorKemik, O.
dc.contributor.authorKemik, A.
dc.contributor.authorSumer, A.
dc.contributor.authorAlmali, N.
dc.contributor.authorGurluler, E.
dc.contributor.authorGures, N.
dc.contributor.authorPurisa, S.
dc.contributor.authorAdas, G.
dc.contributor.authorDogan, Y.
dc.contributor.authorTuzun, S.
dc.date.accessioned2025-10-16T15:33:58Z
dc.date.issued2013
dc.identifier.otherWOS:000328084800014
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/9311
dc.publisherVERDUCI PUBLISHER
dc.sourceEUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
dc.subjectTumor\\-associated trypsin inhibitor
dc.subjectClinical\\-pathological features
dc.subjectGastric cancer
dc.titleThe relationship between serum tumor-associated trypsin inhibitor levels and clinicopathological parameters in patients with gastric cancer
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS